HighCape Capital Acquisition Corp.

Quantum-Si, Inc. develops a protein sequencing platform of proteomics. It offers single molecule analysis, and democratizing its use by providing researchers and clinicians access to the proteome. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Guilford, CT.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Quantum-Si, Inc. engages in the development of a proprietary universal single-molecule detection platform to enable Next-Generation Protein Sequencing, the ability to sequence proteins in a massively parallel fashion. It can be used for the study of nucleic acids. Its platform includes Carbon automated sample preparation instrument, Platinum NGPS instrument, Quantum-Si Cloud software service, and reagent kits and chips for use with its instruments. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Branford, CT.

Quantum-Si

GUILFORD, Conn. & NEW YORK--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSi” or “the Company”), a company pioneering next-generation semiconductor chip-based proteomics, today announced that it has completed its business combination with HighCape Capital Acquisition Corp. (Nasdaq: CAPA) (“HighCape”), a special purpose acquisition company sponsored by leading healthcare growth equity manager HighCape Capital LP. The business combination and concurrent private placement

Quantum-Si, Revolutionizing Proteomics, Closes Business Combination and Will Begin Trading Under the Ticker “QSI” on the Nasdaq Stock Exchange

NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) -- HighCape Capital Acquisition Corp. (Nasdaq: CAPA) (“HighCape”), a special purpose acquisition company sponsored by leading healthcare growth equity investment firm HighCape Capital LP, reminds its stockholders of record as of the close of business on May 10, 2021 to vote at the upcoming special meeting of stockholders held virtually at https://www.cstproxy.com/highcape/sm2021 on June 9, 2021 at 10:00 a.m. Eastern Time (the “Special Meeting”) to approve the proposed business combination with Quantum-Si Incorporated , a company pioneering next-generation semiconductor chip-based proteomics.

HighCape Capital Acquisition Corp. Reminds Stockholders to Vote in Favor of the Business Combination with Quantum-Si Incorporated

Special meeting of HighCape stockholders scheduled for June 9, 2021 Special meeting of HighCape stockholders scheduled for June 9, 2021

Quantum-Si and HighCape Capital Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination

GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today the appointment of Marijn Dekkers, Ph.D. and Ruth Fattori to its Board of Directors. Both Dr. Dekkers and Ms. Fattori have agreed to continue to serve on the Board of Directors of the combined company subsequent to the closing of the previously announced business combination between Quantum-Si and HighCape Capital Acquisition Corp (Nasdaq: CAPA). “

Quantum-Si Strengthens Board of Directors With Two Key Appointments

DraftKings

Fisker Inc

Genesis Park Acquisition Corp.

MP Materials

Chris Katje is a co-host of Benzinga's YouTube show, "SPACs Attack," with Mitch Hoch.  On a recent episode of Benzinga's "SPACs Attack," we offered five long-term SPAC picks for investors to contemplate.

5 Long-Term SPACs For Investors To Consider

GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today the appointment of Michael Mina, M.D., Ph.D., Assistant Professor of Epidemiology, Immunology, Infectious Diseases and Pathology at the Harvard T.H. Chan School of Public Health and Harvard Medical School, as Chief Medical Advisor for the company. “As we create the next generation of protein sequencing and proteomics to transform how we study and d

Quantum-Si Appoints Dr. Michael Mina as Chief Medical Advisor

Larry Robbins ( Trades , Portfolio )'s firm has revealed a new buy into HighCape Capital Acquisition Corp. (NASDAQ:CAPA) according to GuruFocus' Real-Time Picks, a Premium feature.

Larry Robbins' Firm Buys Into HighCape Capital Acquisition

Exact Sciences

Ark Funds hosted an investor webinar Tuesday, sharing ideas on several industries and portfolio components, including a discussion on some names in the genomics space. Ark Funds On Genomics: Ark Funds is well-known for its bullish thesis on the genomics market.

2 Genomic Stocks That Ark Funds Highlighted On Investor Day

Holicity

VG Acquisition Corp.

A rocket company, a 3-D capture software company, and two biotechs are about to hit the public markets. Smart investors can get in now via special purpose acquisition companies.

4 SPACs for the Future

HighCape Capital (CAPA) stock is soaring higher on Thursday with heavy trading after announcing plans for a SPAC merger with Quantum-Si. The post CAPA Stock: 16 Things for to Know About HighCape Capital and the Quantum-Si SPAC Merger appeared first on InvestorPlace.

CAPA Stock: 16 Things for to Know About HighCape Capital and the Quantum-Si SPAC Merger

Shares of special purpose acquisition company HighCape Capital Management LLC exploded as much as 140% on Thursday after the company agreed to buy biotech firm Quantum-Si.  Quantum-Si has created the world's first semiconductor chip that can enable protein sequencing and analyze proteins in a digitized format.

SPAC HighCape Capital soars 140% on deal to buy protein-sequencing firm Quantum-Si

The stock price of Highcape Capital Acquisition Corp (NASDAQ: CAPA) is trading at over 50% pre-market. This is why it happened.

CAPA Stock Price Increases Over 50% Pre-Market: Why It Happened

News for HighCape Capital Acquisition Corp. Stock (CAPA)